A remodeled protein arginine methyltransferase 1 (PRMT1) generates symmetric dimethylarginine

Shanying Gui, Symon Gathiaka, Jun Li, Jun Qu, Orlando Acevedo, Joan M. Hevel

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Protein arginine methylation is emerging as a significant post-translational modification involved in various cell processes and human diseases. As the major arginine methylation enzyme, protein arginine methyltransferase 1 (PRMT1) strictly generates monomethylarginine and asymmetric dimethylarginine (ADMA), but not symmetric dimethylarginine (SDMA). The two types of dimethylarginines can lead to distinct biological outputs, as highlighted in the PRMT-dependent epigenetic control of transcription. However, it remains unclear how PRMT1 product specificity is regulated. We discovered that a single amino acid mutation (Met-48 to Phe) in the PRMT1 active site enables PRMT1 to generate bothADMAand SDMA. Due to the limited amount of SDMA formed, we carried out quantum mechanical calculations to determine the free energies of activation of ADMA and SDMA synthesis. Our results indicate that the higher energy barrier ofSDMAformation (ΔΔG‡ = 3.2 kcal/mol as compared with ADMA) may explain the small amount of SDMA generated by M48F-PRMT1. Our study reveals unique energetic challenges for SDMA-forming methyltransferases and highlights the exquisite control of product formation by active site residues in the PRMTs.

Original languageEnglish (US)
Pages (from-to)9320-9327
Number of pages8
JournalJournal of Biological Chemistry
Volume289
Issue number13
DOIs
StatePublished - Mar 30 2014
Externally publishedYes

Fingerprint

Protein-Arginine N-Methyltransferases
Methylation
Arginine
Catalytic Domain
Energy barriers
Methyltransferases
Transcription
Post Translational Protein Processing
Epigenomics
Free energy
N,N'-dimethylarginine
Chemical activation
Amino Acids
Mutation
Enzymes

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology
  • Medicine(all)

Cite this

A remodeled protein arginine methyltransferase 1 (PRMT1) generates symmetric dimethylarginine. / Gui, Shanying; Gathiaka, Symon; Li, Jun; Qu, Jun; Acevedo, Orlando; Hevel, Joan M.

In: Journal of Biological Chemistry, Vol. 289, No. 13, 30.03.2014, p. 9320-9327.

Research output: Contribution to journalArticle

Gui, Shanying ; Gathiaka, Symon ; Li, Jun ; Qu, Jun ; Acevedo, Orlando ; Hevel, Joan M. / A remodeled protein arginine methyltransferase 1 (PRMT1) generates symmetric dimethylarginine. In: Journal of Biological Chemistry. 2014 ; Vol. 289, No. 13. pp. 9320-9327.
@article{e7f09570dc3c436f84fd70cb7b7cf4a7,
title = "A remodeled protein arginine methyltransferase 1 (PRMT1) generates symmetric dimethylarginine",
abstract = "Protein arginine methylation is emerging as a significant post-translational modification involved in various cell processes and human diseases. As the major arginine methylation enzyme, protein arginine methyltransferase 1 (PRMT1) strictly generates monomethylarginine and asymmetric dimethylarginine (ADMA), but not symmetric dimethylarginine (SDMA). The two types of dimethylarginines can lead to distinct biological outputs, as highlighted in the PRMT-dependent epigenetic control of transcription. However, it remains unclear how PRMT1 product specificity is regulated. We discovered that a single amino acid mutation (Met-48 to Phe) in the PRMT1 active site enables PRMT1 to generate bothADMAand SDMA. Due to the limited amount of SDMA formed, we carried out quantum mechanical calculations to determine the free energies of activation of ADMA and SDMA synthesis. Our results indicate that the higher energy barrier ofSDMAformation (ΔΔG‡ = 3.2 kcal/mol as compared with ADMA) may explain the small amount of SDMA generated by M48F-PRMT1. Our study reveals unique energetic challenges for SDMA-forming methyltransferases and highlights the exquisite control of product formation by active site residues in the PRMTs.",
author = "Shanying Gui and Symon Gathiaka and Jun Li and Jun Qu and Orlando Acevedo and Hevel, {Joan M.}",
year = "2014",
month = "3",
day = "30",
doi = "10.1074/jbc.M113.535278",
language = "English (US)",
volume = "289",
pages = "9320--9327",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "13",

}

TY - JOUR

T1 - A remodeled protein arginine methyltransferase 1 (PRMT1) generates symmetric dimethylarginine

AU - Gui, Shanying

AU - Gathiaka, Symon

AU - Li, Jun

AU - Qu, Jun

AU - Acevedo, Orlando

AU - Hevel, Joan M.

PY - 2014/3/30

Y1 - 2014/3/30

N2 - Protein arginine methylation is emerging as a significant post-translational modification involved in various cell processes and human diseases. As the major arginine methylation enzyme, protein arginine methyltransferase 1 (PRMT1) strictly generates monomethylarginine and asymmetric dimethylarginine (ADMA), but not symmetric dimethylarginine (SDMA). The two types of dimethylarginines can lead to distinct biological outputs, as highlighted in the PRMT-dependent epigenetic control of transcription. However, it remains unclear how PRMT1 product specificity is regulated. We discovered that a single amino acid mutation (Met-48 to Phe) in the PRMT1 active site enables PRMT1 to generate bothADMAand SDMA. Due to the limited amount of SDMA formed, we carried out quantum mechanical calculations to determine the free energies of activation of ADMA and SDMA synthesis. Our results indicate that the higher energy barrier ofSDMAformation (ΔΔG‡ = 3.2 kcal/mol as compared with ADMA) may explain the small amount of SDMA generated by M48F-PRMT1. Our study reveals unique energetic challenges for SDMA-forming methyltransferases and highlights the exquisite control of product formation by active site residues in the PRMTs.

AB - Protein arginine methylation is emerging as a significant post-translational modification involved in various cell processes and human diseases. As the major arginine methylation enzyme, protein arginine methyltransferase 1 (PRMT1) strictly generates monomethylarginine and asymmetric dimethylarginine (ADMA), but not symmetric dimethylarginine (SDMA). The two types of dimethylarginines can lead to distinct biological outputs, as highlighted in the PRMT-dependent epigenetic control of transcription. However, it remains unclear how PRMT1 product specificity is regulated. We discovered that a single amino acid mutation (Met-48 to Phe) in the PRMT1 active site enables PRMT1 to generate bothADMAand SDMA. Due to the limited amount of SDMA formed, we carried out quantum mechanical calculations to determine the free energies of activation of ADMA and SDMA synthesis. Our results indicate that the higher energy barrier ofSDMAformation (ΔΔG‡ = 3.2 kcal/mol as compared with ADMA) may explain the small amount of SDMA generated by M48F-PRMT1. Our study reveals unique energetic challenges for SDMA-forming methyltransferases and highlights the exquisite control of product formation by active site residues in the PRMTs.

UR - http://www.scopus.com/inward/record.url?scp=84897399262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897399262&partnerID=8YFLogxK

U2 - 10.1074/jbc.M113.535278

DO - 10.1074/jbc.M113.535278

M3 - Article

VL - 289

SP - 9320

EP - 9327

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 13

ER -